160 related articles for article (PubMed ID: 26974670)
1. Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer.
Ha HR; Oh DY; Kim TY; Lee K; Kim K; Lee KH; Han SW; Chie EK; Jang JY; Im SA; Kim TY; Kim SW; Bang YJ
PLoS One; 2016; 11(3):e0151406. PubMed ID: 26974670
[TBL] [Abstract][Full Text] [Related]
2. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater.
Krishnan S; Rana V; Evans DB; Varadhachary G; Das P; Bhatia S; Delclos ME; Janjan NA; Wolff RA; Crane CH; Pisters PW
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):735-43. PubMed ID: 17980502
[TBL] [Abstract][Full Text] [Related]
3. Does adjuvant treatment improve prognosis after curative resection of ampulla of Vater carcinoma? A multicenter retrospective study.
Kim HS; Jang JY; Yoon YS; Park SJ; Kwon W; Kim SW; Han HS; Han SS; Park JS; Yoon DS
J Hepatobiliary Pancreat Sci; 2020 Oct; 27(10):721-730. PubMed ID: 32652820
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant therapy for ampullary carcinomas: the Mayo Clinic experience.
Bhatia S; Miller RC; Haddock MG; Donohue JH; Krishnan S
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):514-9. PubMed ID: 16863684
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of lymph node status for patients with ampullary adenocarcinoma after radical resection followed by adjuvant treatment.
Kwon J; Kim K; Chie EK; Kim BH; Jang JY; Kim SW; Oh DY; Bang YJ
Eur J Surg Oncol; 2017 Sep; 43(9):1690-1696. PubMed ID: 28648977
[TBL] [Abstract][Full Text] [Related]
6. Proposed new staging system for ampulla of Vater cancer with greater discriminatory ability: multinational study from eastern and western centers.
He J; Kim JR; Lee SY; Oh J; Park T; Kang MJ; Kwon W; Kim H; Kim SW; Cameron JL; Wolfgang CL; Jang JY
J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):475-484. PubMed ID: 28660632
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer.
Yun SP; Seo HI
BMC Gastroenterol; 2015 Nov; 15():165. PubMed ID: 26603157
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in patients with operable ampullary carcinoma.
Demirci NS; Erdem GU
Bosn J Basic Med Sci; 2018 Aug; 18(3):268-274. PubMed ID: 29131967
[TBL] [Abstract][Full Text] [Related]
9. Impact of preoperative endoscopic cholangiography and biliary drainage in Ampulla of Vater cancer.
Ahn KS; Kang KJ; Kim YH; Lee YS; Cho GB; Kim TS; Lee JW
Surg Oncol; 2018 Mar; 27(1):82-87. PubMed ID: 29549909
[TBL] [Abstract][Full Text] [Related]
10. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
[TBL] [Abstract][Full Text] [Related]
11. Role of adjuvant chemotherapy on recurrence and survival in patients with resected ampulla of Vater carcinoma.
Park SJ; Shin K; Kim IH; Hong TH; Kim Y; Lee MA
World J Gastrointest Oncol; 2023 Apr; 15(4):677-688. PubMed ID: 37123060
[TBL] [Abstract][Full Text] [Related]
12. Survival benefit of concurrent chemoradiotherapy for advanced ampulla of Vater cancer.
Kwon CH; Seo HI; Kim DU; Han SY; Kim S; Lee NK; Hong SB; Ahn JH; Park YM; Noh BG
World J Clin Cases; 2024 Jan; 12(2):267-275. PubMed ID: 38313654
[TBL] [Abstract][Full Text] [Related]
13. Surgical outcomes and prognostic factors for ampulla of Vater cancer.
Choi SB; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
Scand J Surg; 2011; 100(2):92-8. PubMed ID: 21737384
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
Narang AK; Miller RC; Hsu CC; Bhatia S; Pawlik TM; Laheru D; Hruban RH; Zhou J; Winter JM; Haddock MG; Donohue JH; Schulick RD; Wolfgang CL; Cameron JL; Herman JM
Radiat Oncol; 2011 Sep; 6():126. PubMed ID: 21951377
[TBL] [Abstract][Full Text] [Related]
15. Distinct immunological properties of the two histological subtypes of adenocarcinoma of the ampulla of Vater.
Kim MH; Jang M; Kim H; Lee WJ; Kang CM; Choi HJ
Cancer Immunol Immunother; 2019 Mar; 68(3):443-454. PubMed ID: 30604042
[TBL] [Abstract][Full Text] [Related]
16. Impact of lymph node metastasis on survival in patients with pathological T1 carcinoma of the ampulla of Vater.
Terasawa H; Uchiyama K; Tani M; Kawai M; Tsuji T; Tabuse K; Kobayashi Y; Taniguchi K; Yamaue H
J Gastrointest Surg; 2006 Jun; 10(6):823-8. PubMed ID: 16769538
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant Chemotherapy for Resected Ampulla of Vater Carcinoma: Retrospective Analysis of 646 Patients.
Kim JH; Jeong JH; Ryoo BY; Kim KP; Chang HM; Oh D; Song TJ; Lee SS; Seo DW; Lee SK; Kim MH; Park Y; Kwon JW; Hwang DW; Lee JH; Lee W; Kim SC; Yoo C; Song KB
Cancer Res Treat; 2021 Apr; 53(2):424-435. PubMed ID: 33171024
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
Falconi M; Crippa S; DomÃnguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
[TBL] [Abstract][Full Text] [Related]
19. Role of adjuvant chemoradiotherapy for ampulla of Vater cancer.
Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):436-41. PubMed ID: 19394162
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
